Deep dive · NYQ: NVO
Novo Nordisk A/S stock analysis
Everything behind the call on Novo Nordisk A/S. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Global tapeOverseas lean-1.97%
FrankfurtNOVA-2.17%⏱MéxicoNVON-2.56%⏱London0TDD-3.13%⏱ZurichNVO0.00%⏱
Where else this company trades. A closed venue shows its last close, marked ⏱ — not a live price. Overseas lean is the average move across the 4 overseas venues listed above, excluding the home listing — a read on overnight sentiment rather than a signal.
The bottom linestart hereAs of 2026-09-18
Wall Street rating
Hold
+9% to the average target
21% buy · 71% hold · 7% sell
median target $47
median target $47
Chart pattern
Below both averages
The 50-day sits above the 200-day
50-day $46.58 · -7.2%
200-day $44.98 · -3.9%
200-day $44.98 · -3.9%
Earnings
In 47 days
4 Nov 2026 · options imply ±4.7%
beat 5–6 of the last 8
cohort P(beat) 64% · n=45,184
cohort P(beat) 64% · n=45,184
Valuation
12.9× forward
1st of its own five-year range
5yr median 36×
FCF yield 15.19%
FCF yield 15.19%
Dividend
4.16%
Forward annual yield at today's price
Risk flags
2 on watch
5 checks run, 3 clear
beta 1.13 · vol 33% ann.
worst drawdown -44%
worst drawdown -44%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does148 chars
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
NYQ · USDGeneral Pharmaceutical
$43.24+0.05 · +0.12%CLOSED · vol 10.35M
52-week range↑ 23% off low · ↓ 32.6% off high
$35.12now $43.24$64.16
Quote Sep 18, 2026 · 12:25 PM ET
Tape 2026-09-17
Factors 2026-09-18
Tape 2026-09-17
Factors 2026-09-18
01Ratios · Jun 21, 2026SOLVENCY IN QUESTION
Survival & solvency
Altman-Z of 2.1 against a 3.0 safe threshold, and 3 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Bankruptcy risk (Altman-Z)
2.13GREY ZONE
Distress<1.8
Grey1.8–3.0
Safe>3.0
Profitability, leverage and liquidity combined into one number. Above 3.0 is the safe band.
Balance sheetJun 21, 2026
Distance to default (Merton)THIN
2.7σ
How many standard deviations of asset value sit between the company and its debt. Above 4σ is comfortable.
1-year default probabilityEDF-CALIBRATED
0.83%
Calibrated against how often companies at this distance actually defaulted, rather than assuming a normal distribution.
Piotroski F-scoreWATCH
F 5/9
Piotroski F-score 5 of 9. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills0.80×healthy >2
Debt / equityborrowings against shareholder capital0.67
Net debtborrowings in excess of cash on hand$104.49B
Your ownership stake
Share-count growth vs peersLOW DILUTION
18th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Accounting forensicsSEC filings
Red-flag x-rayGRADE B
80 / 100
0 critical · 2 watch · 3 clear of 5 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressWATCHZ 2.12Altman-Z in the Grey · fundamentals
Earnings manipulationCLEARM -2.62M-score in range · fundamentals
LeverageCLEARLTD/E 0.58long-term debt 0.58× equity · fundamentals
Profitability qualityWATCHF 5/9Piotroski F-score 5 of 9 · fundamentals
Filing forensicsCLEAR0 flagsno filing red flags on the latest 10-K · forensic
5 checks, 3 clear and 2 watch. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 18, 2026GOOD · 61/100
Business quality
33% net margin, 53% return on equity, +6% revenue growth, and capital earning 38% against a 7% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
61 / 100GOOD
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 18, 2026
Net marginOF EVERY SALES DOLLAR
33.1%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
81.0%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
41.3%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
52.8%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadCREATES VALUE
30.6pp
Earns 38% on invested capital that costs about 7%. A positive spread means every retained dollar compounds rather than leaks.
Incremental ROIC (3y)ON NEW CAPITAL
19.8%
The return on capital put to work over the last three years — a sharper read than the trailing average, because it prices the newest decisions.
Growth & relative strength
Trailing return by period
1 month-7.1%
3 months0.0%
6 months+16.5%
Year to date-17.6%
1 year-25.8%
Revenue growth (YoY)GROWING
+6.4%
Revenue against the same period a year ago.
EPS growth (YoY)IN LINE
+1.8%
Earnings per share against a year ago. Running ahead of revenue means margins are widening.
12-1 momentumEX LAST MONTH
-16.1%
Return over the last year excluding the most recent month — the standard momentum factor, which drops the short-term reversal.
Relative-strength rankTOP 45%
56 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earningsAug 4, 2026
P(beat next quarter)COHORT BASE RATE
64%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameBEAT 5–6 OF THE LAST 8
6 of 8
Its own record against consensus. 8 prints is a small sample, which is why the cohort rate above carries the probability.
Fell after a beatP(FELL | BEAT)
33%
A beat is not a plan: this share of them still closed lower on the day.
Rose after a missP(ROSE | MISS)
29%
The mirror of the line above, over its own denominator.
Typical earnings moveMEDIAN ABSOLUTE
±3.8%
Unsigned magnitudes from its own prints. Direction is not part of this read.
Reaction: beat vs missASYMMETRIC
+1.1% / -4.2%
The average day-one move after a beat and after a miss. A miss dropping the stock further than a beat lifts it is the asymmetry worth sizing for.
Dividends & income
Dividend yieldforward annual
4.16%
The cash return the payment alone provides at today's price.
Cash coveragefree cash flow
<1x
Whether the payment is funded out of the cash the business generates.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 18, 2026
Downtrend · leans bearish
HorizonHigherMedianObservations
10d47%0.0%1,260,321
21d48%0.0%593,656
63d47%-0.5%186,156
slope -0.11 over 40 bars
Three black crows · leans bearish
HorizonHigherMedianObservations
10d51%+0.1%310,689
21d50%0.0%146,312
63d49%-0.4%46,362
three falling red bars
Double top · leans bearish
HorizonHigherMedianObservations
10d50%0.0%1,212,095
21d51%+0.1%570,206
63d52%+0.4%180,573
two peaks ≈ equal — reversal if neckline breaks
Double bottom · leans bullish
HorizonHigherMedianObservations
10d49%0.0%1,242,409
21d50%0.0%584,002
63d51%+0.2%184,289
two troughs ≈ equal — reversal if neckline breaks
Triple bottom · leans bullish
HorizonHigherMedianObservations
10d49%0.0%961,327
21d50%+0.1%451,185
63d52%+0.3%141,927
three troughs ≈ equal
Ascending triangle · leans bullish
HorizonHigherMedianObservations
10d50%0.0%643,427
21d51%+0.2%302,356
63d53%+0.5%95,587
flat resistance, rising support
031ST OF ITS 5-YEAR RANGE
Price & timing
Price $43.24, 12.9× forward earnings, RSI 42, and dealers short gamma.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Trend
Below every average0 OF 3 AVERAGES
50-day $46.58 · 200-day $44.98. Price above both is the structural definition of an uptrend.
The setup right now
Price · 504 sessions2024-09-13 → 2026-09-17
price50-day200-daylevel
How to read this
Up 0.12% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
The dashed levels are the strikes the options chain is most committed to. They are the same numbers the gamma block states; nothing here is drawn that no section derives.
Momentum (RSI-14)COOL
42
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
Typical day (ATR-14)±2.7%
$1.18
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDBELOW SIGNAL
-0.26
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position21% OF RANGE
Mid band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
20-day VWAPPRICE BELOW
$45.42
The volume-weighted average of the last month. Price above it means recent buyers are, on average, in profit.
Chandelier exitBROKEN
$45.13
A volatility-based trailing stop, set a few average ranges below the recent high.
4 Nov 2026 · in 47 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 28 Aug; companies confirm about three weeks ahead, so it can still move.
2026-09-25 · in 7 daysConsumer SentimentA scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Pullback riskoverstretch read
In line1.02× segment rate · n=7,908
Historically, large names in this tape state saw a ≥10% pullback within 63 trading days in 68% of cases (n=7,908).
Overstretchvs the 20-day mean
-1.2σ
How many standard deviations price sits from its 20-day mean. Beyond 2σ is genuinely stretched; inside it is ordinary.
Bottom zoneif it breaks down
$41 – $433 supports
Where prior demand appeared: Pivot low at $43.13, S1 at $42.29, Pivot low at $41.98.
Slide scorefalling-knife check
35 / 100Neutral
A composite of consecutive down days, gap risk and volume expansion. Low means any decline is orderly.
Signal
The odds lean, the stretch qualifies it.
Not enough fundamental coverage to score this name's red-flag cohort — no 12-month odds shown.
Valuation
Earnings yield vs cashABOVE CASH
3.86pp
The earnings yield clears the risk-free rate, so the current return alone competes with cash.
Net cash per shareNET DEBT
$-23.40
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Forward P/Eearnings expected over the next 12 months12.9×5yr median 36×
Trailing P/Eearnings already reported10.3×1st of its 5yr range
Price / salesprice against revenue, before any of it becomes profit0.6×5yr median 11.8×
Price / bookprice against the accounting value of the assets1.0×
EV / EBITDAthe multiple an acquirer would pay2.0×
EV / free cash flowenterprise value against the cash the business throws off10.2×
FCF yieldfree cash flow per dollar of market value15.19%
0 of the 7 priced multiples above sit in the richer half of its band. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timingSep 17, 2026
Entryzone of pivot low + S1
$42.97In zone
Where the composer's entry sits, on its own stated basis.
TargetRound + sma 200
$44.98$45–$45
A zone, not a price. It is where the composer expects supply, not a forecast.
Stop2× ATR below entry
$40.62risk $2.36/sh
The level that says the setup is wrong, on the basis named beside it.
Risk / rewardtarget vs stop
0.85:1flagged low
Less reward than risk at these levels. The composer publishes it rather than hiding it, because a sub-1 ratio is the argument against the trade.
Measure from a price$
To the 50-day
+7.7%
short-term trend line · $46.58
To the 200-day
+4.0%
primary trend line · $44.98
To the put wall
+7.5%
heaviest put open interest · $46.50
To the call wall
+11.0%
heaviest call open interest · $48.00
To the composer's target
+4.0%
Round + sma 200 · set Sep 17, 2026 · $44.98
To the composer's stop
-6.1%
2× ATR below entry · set Sep 17, 2026 · $40.62
To the 52-week high
+48.4%
highest print of the past year · $64.16
To the 52-week low
-18.8%
lowest print of the past year · $35.12
Options-implied week ±4.7%
$41.20 – $45.28
what the chain prices for the week
A typical day (ATR)
$42.06 – $44.42
±$1.18 average true range
Type any price to re-measure every distance from it. Each row is a level this page already states somewhere else, so nothing here is a new number — and none of it is a recommendation to trade at that price.
Signal
Less reward than risk at this level.
Entry $42.97 · stop $40.62 · target $44.98, a 0.85:1 ratio. The composer flagged: fair-value reference, low reward to risk.
Gamma mapChain · Sep 18, 2026
Signal
Short gamma — moves get amplified.
Dealers hedge in the same direction as the move, so swings get bigger both ways rather than one. That argues for a smaller position size, not for a direction.
Options tapeLast snapshot before the 2026-09-04 expiry · Chain · Sep 18, 2026
Max pain-0.4%
$46.50
The strike where most open options would have expired worthless on the last snapshot. That expiry has passed; the next chain read replaces it.
Put / call ratio (OI)CALL-HEAVY
0.37
73% calls
27% puts
Open interest in puts against calls. Heavy call interest often caps how far price can run before expiry.
Put / call ratio (volume)TODAY'S FLOW
0.31
Today's traded flow rather than the standing position. It moves faster and means less.
Expected move (1-week)≈ $2.20
±4.7%
What the chain prices for the week. A range the market is charging for, not a forecast.
Largest open interest · front expiry
StrikeTypeOpen interest
$48.00CALL3,471
$50.00CALL3,166
$47.50CALL2,279
$47.00CALL1,508
$48.50CALL1,452
$46.00CALL1,403
Large call interest above the price acts as a magnet and a ceiling; large put interest below is a floor of hedges. The biggest strike is the level the market is most committed to defending into the next expiry.
Open interest by strikeexpires 2026-09-04 (expired)CallsPutsMax pain $46.50
3k
$50.00
0471
$49.50
0833
$49.00
851k
$48.50
1583k
$48.00
2612k
$47.50
1292k
$47.00
939980
$46.50
1k1k
$46.00
852420
$45.50
367397
$45.00
89510
$44.50
549108
$44.00
3764
$43.50
50620
$43.00
3196
$42.50
45
The shaded row is the strike nearest the price. Heavy call interest above acts as a ceiling; heavy put interest below is a floor of hedges.
↑ 52-week high$64.16+37.4%The highest print of the past year.Old highs draw profit-taking on the first attempt.
↑ Call wall$48.00+2.8%Heaviest call open interest on the front expiry.Acts as a ceiling into expiry; a close above usually needs a catalyst.
◇ Max pain$46.50-0.4%Where most open options expire worthless.Price often drifts toward it into the close of the expiry week.
↓ 50-day average$46.58-0.2%The line the short-term trend is measured against.A close beneath it is the first structural warning.
↓ Put wall$46.50-0.4%Heaviest put open interest — a floor of hedges.Dealer buying tends to build as price approaches.
0413F quarterly · Form 4 dailyNET SIGNAL 0
Ownership & flow
Institutions hold 10%, short interest is 1.00% of float, and 7 analysts average $47.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
0BALANCED · 30d
1 bull / 1 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Analyst moves90D · TIMING
-2
1 analyst downgrade in 90d
Earnings4 QUARTERS · TIMING
+2
latest EPS beat by 24%
Signal
1 bull / 1 bear factors
Independent factors scored and netted to 0 over 30d, a balanced reading. 2 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category read
Data unavailableFewer independent evidence families are ready than the engine's minimum, so there is nothing to check for agreement. A cross-category read over two categories is not a read.
Wall Street7 covering firms
Consensus rating7 ANALYSTS
Hold
21% buy · 71% hold · 7% sell, as a share of the 7 covering firms.
Median price target+9%
$47
$40now $43$63
A $40–$63 spread across the panel. A twelve-month view, and a wide spread means real disagreement rather than a consensus.
Forward EPS estimateCONSENSUS
$21.91
What the panel expects the company to earn per share.
Recent analyst moves · last 90 days
FirmTargetDirectionRank
Morgan Stanley$40↓50/100
Upgrades, downgrades and target changes from covering firms. A cluster of moves in one direction matters more than any single target; the rank is the firm's own credibility score, or a dash below the scoring floor.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipRETAIL-HEAVY
9.9%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
0.0%
The share held by the people running the company.
Short interest (float)LIGHT
1.00%
Rising — shares short changed +7.6% over 30 days. There is no short base to squeeze here.
Free float95% OF SHARES
3.17B
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)97th PCTILE
$497.70M/day
At this depth, position size is not a constraint for a retail account.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved todayNEWS
+0.12%
NVO was little changed +0.12% in after-hours trading, amid recent coverage: “Novo's Denecimig Gets CHMP Nod for Hemophilia A in the European Union” (Zacks).
News tone · 7-day—
64 / 100
Headline polarity over the window, scored from news articles. Above 60 leans positive, below 40 negative. Colour, not a signal.
Newswire · 50 stories
WhenHeadlineSourceTone
8h agoNovo's Denecimig Gets CHMP Nod for Hemophilia A in the European UnionZacksnot scored
19h agoSandoz Gets Canada Approval for Generic Version of OzempicThe Wall Street Journalnot scored
ThuNovo Nordisk (NVO) Pulls the Plug on Two More Heart Drug TrialsInsider Monkeynot scored
ThuNovo Nordisk (NVO) Pulls the Plug on Two More Heart Drug Trials - Yahoo FinanceYahoo Financenot scored
ThuIs Novo Nordisk (CPSE:NOVO B) A Bargain Following The FREHEMGO CHMP Green Light?Simply Wall St.not scored
ThuAscendis Pharma (ASND) Will Regain Metabolic Drug Rights. Is Greater Ownership Worth the Cost?Insider Monkeynot scored
ThuNovo Nordisk's hemophilia drug clears a key hurdle in EuropeGuruFocus.comnot scored
ThuNVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia PenStocktwitsnot scored
Coverage published around the move, newest first. Nothing here measures causation — only the why-it-moved card above is matched to the tape by timestamp.
CongressSTOCK Act · 30–45d lag
Signal
Net buying.
4 of 6 disclosures are buys and 2 are sales. Lawmakers disclose on a 30–45 day legal lag, so this describes what was done weeks ago, not what is being done now.
0510 graded callsORDINARY VOLATILITY
Risk & track record
Beta 1.13, 33% annual volatility, a -44% worst drawdown, and 4 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-43.7%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
Beta (vs the market)LOW FIT
1.13
The market explains about 9.9% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityORDINARY
33%
How far it swings over a year, from its own realized returns.
Tactical phaseNIGHTLY READ
Neutral
Selling pressure52
Buying pressure0
Overheat0
State: neutral — No dominant short-horizon pressure in the tape.
What votes againstNightly
MedAnalyst moves1 analyst downgrade in 90d90d · -2
Signal
1 of 9 factors vote against.
Ranked by the size of each factor's own point contribution to the net signal — these are the model's stated reasons, not a written bear case. Each one is scored from the source named beside it.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
3.3%tail cap binds
max defensible size 3.3% - tail binds
Avoid score6-month distress
4.9%0.5× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.5× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 44.3% · tail cap 3.3% · category cap 90.1%. The tail cap binds, so 3.4% is the number (n=25,762). We show which one binds rather than the friendliest.Sizing
LowLottery-ticket behaviourIts best 21-day return sits at 3.7% against a 8.7% cohort 90th-percentile threshold — below the line where forward returns have historically turned negative.Behaviour
LowCash runwayNon-burner: catastrophe rate 6.1% (n=297414).Solvency
LowPost-earnings driftDrift odds at full strength (+3.21% / 63-day spread reference from measured post-earnings drift).Timing
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
4 of 8 surfaces clear.
8 surfaces checked, 4 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You can't sit through -44%
That is this name's deepest measured fall, on 33% annualized volatility. A drawdown of that size is normal here, not exceptional.
Our track record10 resolved
Track recordBUILDING IN THE OPEN
22 logged
22 calls logged on this name, 10 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on NVOTHIS NAME
22
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 10.
0610-K disclosed linksGENERAL PHARMACEUTICAL
The wider context
5 mapped peers, 18 connections.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
-0.4% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
LLYCompetitor$1,152.93+0.04%
JNJPeer$269.99-0.09%
ABBVPeer$263.96-0.02%
MRKPeer$146.87-0.19%
AZNPeer$166.08-0.04%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
1 of 4 backward windows are positive.
Look-back returns describe what happened, not what is likely. They are here to set the scale a future move would be measured on.
Macro driversRolling window
Inflation (CPI) reactionn=39
0.87×
On these days it moves about 0.9× the market, regardless of company news.
Jobs report reactionn=40
1.17×
On these days it moves about 1.2× the market, regardless of company news.
Fed decision (FOMC) reactionn=39
1.16×
On these days it moves about 1.2× the market, regardless of company news.
Inflation (PCE) reactionn=39
1.14×
On these days it moves about 1.1× the market, regardless of company news.
Next macro catalystIN 7 DAYS
Consumer Sentiment
2026-09-25. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 18, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day 0.0% · A week later +0.5% · Two weeks later +1.0% · Rose on 83 of 169 report days
Across the last 169 Initial jobless claims reports since Jun 8, 2023, NVO moved 0.0% on average on the day and was 1.0% higher two weeks later. The S&P 500 moved 0.0% on those days.
On the day +2.8% · A week later +2.2% · Two weeks later +1.5% · Rose on 21 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, NVO moved +2.8% on average on the day and was 1.5% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day -0.1% · A week later +1.4% · Two weeks later +0.4% · Rose on 17 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, NVO moved -0.1% on average on the day and was 0.4% higher two weeks later. The S&P 500 moved +0.1% on those days.
Producer prices (PPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.3% · A week later -0.9% · Two weeks later +0.9% · Rose on 22 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, NVO moved +0.3% on average on the day and was 0.9% higher two weeks later. The S&P 500 moved +0.3% on those days.
On the day -0.1% · A week later +1.4% · Two weeks later +0.4% · Rose on 17 of 39 report days
Across the last 39 Retail sales reports since Jun 15, 2023, NVO moved -0.1% on average on the day and was 0.4% higher two weeks later. The S&P 500 moved +0.1% on those days.
Consumer sentiment (UMich) is due in 6 days.
Consumer sentiment (UMich)Little effect either wayLittle direct link.
Typical for the Healthcare sector
On the day -0.2% · A week later -0.7% · Two weeks later -0.3% · Rose on 17 of 38 report days
Across the last 38 Consumer sentiment (UMich) reports since Jun 26, 2023, NVO moved -0.2% on average on the day and was 0.3% lower two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 11 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.6% · A week later -0.7% · Two weeks later +1.1% · Rose on 19 of 38 report days
Across the last 38 Core PCE (the Fed's gauge) reports since Jun 28, 2023, NVO moved -0.6% on average on the day and was 1.1% higher two weeks later. The S&P 500 moved +0.2% on those days.
Core inflation (core CPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.2% · A week later -0.9% · Two weeks later +0.9% · Rose on 21 of 38 report days
Across the last 38 Core inflation (core CPI) reports since Jun 12, 2023, NVO moved +0.2% on average on the day and was 0.9% higher two weeks later. The S&P 500 moved +0.3% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections18 links · 2 confirmed
Direct connections · 18 edges
CompanyRelationSessionProvenance
LLY · Competitorcompetitor+0.04%Rumored · manual
WST · Customercustomer-1.17%Rumored · manual
CATALENT · Mergerpartnernot pricedRumored · manual
CATALENT · Partnerpartnernot pricedRumored · manual
COR · Suppliersupplier-0.20%Rumored · manual
HIMS · Competitorcompetitor+0.36%Rumored · manual
MCK · Suppliersupplier-0.56%Rumored · manual
CAH · Suppliersupplier-0.42%Rumored · manual
VKTX · Competitorcompetitor-1.26%Rumored · manual
RYTM · Competitorcompetitor-1.32%Confirmed · manual
ASND · Competitorcompetitor-0.97%Confirmed · manual
AMGN · Competitorcompetitor+1.55%Rumored · 10K
CTLT · Suppliersuppliernot pricedRumored · 10K
YPS.SW · Suppliersuppliernot pricedRumored · press
WST · Suppliersupplier-1.17%Rumored · 10K
ROG.SW · Competitorcompetitornot pricedRumored · press
PFE · Competitorcompetitor+0.07%Rumored · 10K
STVN · Suppliersupplier-4.28%Rumored · 10K
2 of 18 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Suppliers, customers & competitors
Named competitors
Who depends on it
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.